Jane Street Group, LLC Biofrontera Inc. Transaction History

Jane Street Group, LLC

  • $72.9 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
SELL
$0.77 - $1.05 $3,093 - $4,217
-4,017 Reduced 26.67%
11,047 $10,000
Q3 2022

Nov 14, 2022
BUY
$0.82 - $1.26 $3,996 - $6,141
4,874 Added 47.83%
15,064 $16,000
Q2 2022

Aug 16, 2022
BUY
N/A
10,190 New
10,190 $19,000

About Biofrontera Inc.

BFRI Quotes by TradingView
  • Ticker BFRI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 23,551,000
  • Market Cap $21M
  • Description
  • Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company offers Ameluz, which is a prescription drug approved for use in combination with the company's licensor's medical device; and the RhodoLED lamp series for phot...
More about BFRI
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email